The effects of ABT‐229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats
- 1 January 1999
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 29 (1) , 33-40
- https://doi.org/10.1046/j.1365-2362.1999.00364.x
Abstract
Background: Interdigestive small bowel motility has a regulatory function on the microflora of the upper small bowel. Here we investigate the effects of ABT‐229 and octreotide on morphine‐induced dysmotility, the accompanying bacterial overgrowth and bacterial translocation.Methods: Rats were fitted with jejunal myoelectrodes and a subcutaneous cannula for continuous infusion of saline or morphine. Fasting motility was measured for 6 h on four occasions: one control measurement (day 0) and three measurements on consecutive days (days 1–3) while receiving saline alone (group A), morphine alone (group B), saline + ABT‐229 (group C), morphine + ABT‐229 (group D), saline + octreotide (group E) or morphine + octreotide (group F). Samples from the mesenteric lymph node complex (MLN), liver, spleen, duodenum and ileum were taken for quantitative microbial culturing on day 4.Results: Neither ABT‐229 nor octreotide increased the number of propagated activity fronts during saline infusion. During morphine‐induced dysmotility, ABT‐229 induced more propagated activity fronts in group D (13.4, 9.8 and 8.8 per 6 h) than in group B (7.0, 4.5, 3.8 per 6 h) on days 1, 2 and 3 (P < 0.05 for all days) Octreotide did not induce more propagated activity fronts. Disruption of small bowel motility by morphine led to bacterial overgrowth in the duodenum. ABT‐229 and octreotide did not reduce the bacterial growth levels. The total incidence of bacterial translocation was significantly higher in the morphine‐treated animals than in the saline‐treated animals. Neither ABT‐229 nor octreotide reduced the bacterial translocation incidence. The number of propagated activity fronts on day 3 and duodenal bacterial growth correlated significantly in groups A, E and F.Conclusions: ABT‐229, but not octreotide, reduced morphine‐induced dysmotility. Small bowel bacterial overgrowth and bacterial translocation were not prevented. Fasting small bowel motility has a regulatory function on the intestinal microflora of the upper small bowel.Keywords
This publication has 26 references indexed in Scilit:
- Octreotide Acetate Inhibits Motility in the Rabbit Distal ColonEuropean Surgical Research, 1997
- Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing proteinGastroenterology, 1996
- Cholecystokinin Increases Small Intestinal Motility and Reduces Enteric Bacterial Overgrowth and Translocation in Rats with Surgically Induced Acute Liver FailureDigestion, 1996
- Cisapride Prevents Enteric Bacterial Overgrowth and Translocation by Improvement of Intestinal Motility in Rats with Acute Liver FailureEuropean Surgical Research, 1996
- Octreotide does not prevent bacterial translocation in an infant piglet model of intestinal ischemia-reperfusionJournal of Pediatric Surgery, 1995
- Localization of motilin-immunopositive cells in the rat intestine by light microscopic immunocytochemistryPeptides, 1994
- Alterations in rat intestinal transit by morphine promote bacterial translocationDigestive Diseases and Sciences, 1993
- Effect of Total Parenteral Nutrition Plus Morphine on Bacterial Translocation in RatsAnnals of Surgery, 1993
- Evaluation of the refractory period of the human migrating motor complex through induction of premature Phase IIINeurogastroenterology & Motility, 1992
- Backwards and forwards with the migrating complexDigestive Diseases and Sciences, 1981